Broadfin Healthcare Master Fund Ltd
CIK 1511900 · last filed 2022-02-15
Broadfin Healthcare Master Fund Ltd is a corporate insider who has filed 18 SEC Form 4 insider transactions across 9 companies since 2014. The most recent filing shows the insider converted $13.1M of BDSI on Feb 15, 2022. Across all open-market trades the lifetime net is −$21.7M, making them a net seller over the disclosed history. The firm reports its address in Grand Cayman, E9. 75 SEC filings were submitted jointly with Broadfin Capital, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
9
18
-$21.67M
Filer Profile
ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344
GRAND CAYMAN, E9 KY1-1108
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI) Delisted | Director | 7,588,395 | $5.59 | $42.42M | $0 | 1 | 2022-02-15 |
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Director | 3,130,573 | $21.64 | $67.75M | $0 | 1 | 2019-02-04 |
| Societal CDMO, Inc. (REPH) Delisted | 10%+ Owner | 2,476,025 | $2.09 | $5.17M | -$13.53M | 3 | 2017-12-22 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 2,728,601 | $58.70 | $160.17M | -$3.25M | 1 | 2017-11-20 |
| Corium International, Inc. (CORI) Delisted | 10%+ Owner | 3,593,626 | — | — | -$16.44M | 1 | 2017-11-17 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | 10%+ Owner | 5,184,942 | — | — | $0 | 1 | 2017-05-22 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | 10%+ Owner | 7,599,869 | — | — | $12.20M | 2 | 2017-02-09 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | 10%+ Owner | 4,361,291 | — | — | $393.8K | 1 | 2016-09-14 |
| STRATA Skin Sciences, Inc. (SSKN) Delisted | 10%+ Owner | 24,166 | $0.15 | $3.6K | -$1.04M | 1 | 2016-03-14 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-15 | BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI) Delisted | Conv (C) | +7,266,666 | $13.08M | EDGAR |
| 2021-11-15 | — | Buy (P) | +300,000 | $960.0K | |
| 2021-11-09 | — | Buy (P) | +773,400 | $2.68M | |
| 2020-03-19 | — | Mixed | −31,869 | -$93.4K | |
| 2019-05-14 | — | Mixed | −5,400,000 | -$27.00M | |
| 2019-02-04 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +83,700 | $0 | EDGAR |
| 2018-08-16 | — | Exer (M) | +9,372 | $0 | |
| 2018-08-03 | — | Grant (A) | — | $0 | |
| 2017-12-22 | Societal CDMO, Inc. (REPH) Delisted | Sell (S) | −228,000 | -$2.25M | EDGAR |
| 2017-11-30 | Societal CDMO, Inc. (REPH) Delisted | Sell (S) | −667,848 | -$6.40M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.